Raw Material Variability: The Need for Deeper Process Understandi…
December 5, 2019 - GE Healthcare Life Sciences
Principles and methodologies for biopharmaceutical development and manufacturing are well established today. However, the increased molecular diversity and drive f…
Process Development and Optimization Using the ReadyToProcess WAV…
December 5, 2019 - GE Healthcare Life Sciences
Download this application note to learn about the technical feasibility of the Method editor and operations in dual mode (where two parallel cultures are controlle…
New Therapies Present Scaling Challenges
December 5, 2019 - BioPharm International
New Therapies Present Scaling Challenges
Manufacturing differences between traditional mAb therapies and newer biotherapeutics dictate whether processes should be …
A Diverse Landscape of Patent Issues Seen in the US, UK, and the …
December 5, 2019 - BioPharm International
A Diverse Landscape of Patent Issues Seen in the US, UK, and the EU
Legal experts in biopharmaceutical patent law shed some light on trends and recent news.
…
GE Healthcare Life Sciences to Expand KUBio Through Close Collabo…
December 5, 2019 - GE Healthcare Life Sciences
GE Healthcare Life Sciences has announced it will be working closely with Pharmadule Morimatsu to expand its KUBio “factory in a box” so that biopharma manufac…
Fundamentals of Hydrophobic Interaction Chromatography
November 21, 2019 - GE Healthcare Life Sciences
This article explores the fundamentals and applications of hydrophobic interaction chromatography using Capto™ resins to increase productivity.
Click here t…
Efficient and Scalable Buffer Preparation
November 21, 2019 - GE Healthcare Life Sciences
This article describes how to ensure a scalable process for buffer management from process development to manufacturing with inline conditioning (IC). It also explai…
Collaborative PD Outsourcing: Why Closer is Better
November 21, 2019 - GE Healthcare Life Sciences
Sharing process details externally might seem too close for comfort, but when it comes to process development (PD) outsourcing, a close collaboration can act…
Optimizing Drug Safety and Efficacy of Complex Next-Generation Bi…
November 21, 2019 - GE Healthcare Life Sciences
In recent years, the global biopharma industry has seen a rapidly advancing trend toward biotherapeutics or ‘biologic’ drugs—drugs that are produced from liv…
Biosimilar Quality Requirements
November 21, 2019 - BioPharm International
This article reviews FDA’s recent efforts to streamline the biosimilar approval process and address quality concerns with the publication of new guidelines that …